1. Pink Sheet
  2. >>Geography
  3. >>North America
  4. >>United States

Track And Trace: Substandard System Is Not Better Than Nothing, FDA Says

 
• By Derrick Gingery

CDER Director Janet Woodcock says an industry coalition’s proposal would not meet FDA’s drug tracking needs and is not worth the cost of implementing, even though industry says FDA’s preference is cost-prohibitive.

In the case of drug-tracking requirements, FDA does not feel something is better than nothing.

Lawmakers still have not come to an agreement on a national drug-tracking system standard to allow companies and the agency to monitor where shipments and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America